- CSR Summary Not Yet Available
- NCT00246233
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaBehaviors and Mental DisordersEnrollment145% Female64.8%% White97.9%
Product ClassStimulants/ADHD/AnorexiantsSponsor Protocol Number42603MDD3001 (CON-CAN-3)Data PartnerJohnson & JohnsonCondition StudiedDepressive Disorder, MajorMean/Median Age (Years)43.8
Supporting Documentation
- Data Definition Specification Available
- Protocol with Amendments Available
- Clinical Study Report Available